Open Menu Close Menu

Oxalys Pharmaceuticals, Inc.

Location: Toronto | Ontario

Industry Focus: Healthcare  

Subsectors: Biotechnology 

Oxalys Pharmaceuticals is a Toronto-based, early-stage MIT spin-off company developing small molecule therapeutics to address unmet medical needs in neurodegenerative diseases. Oxalys’ lead therapeutic, OXD-4, targets fundamental pathology behind cognitive decline and brain atrophy, and is on track for clinical trials in Huntington's disease patients in 2015.

Get in Touch with Oxalys Pharmaceuticals, Inc.

* indicates required